Cobalt speciation assay for human serum, Part I. Method for measuring large and small molecular cobalt and protein-binding capacity using size exclusion chromatography with inductively coupled plasma-mass spectroscopy detection

References

• Alexander, C.S. 1972. “Cobalt-Beer Cardiomyopathy: A Clinical and Pathologic Study of Twenty-Eight Cases.” American Journal of Medicine 53: 395–413.
   PubMed Web of Science ®Google Scholar
• ATSDR. 2004. Toxicological Profile for Cobalt. U.S. Department of Health and Human Services, Public Health Service. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
   Google Scholar
• Bar-Or, D., R. Bar-Or, L.T. Rael, D. K. Gardner, D.S. Slone, and M.L. Craun. 2005. “Heterogeneity and Oxidation Status of Commercial Human Albumin Preparations in Clinical Use.” Critical Care Medicine 33: 1638–1641.
   PubMed Web of Science ®Google Scholar
• Bar-Or, D., E. Lau, and J.V. Winkler. 2000. “A Novel Assay for Cobalt-Albumin Binding and its Potential as a Marker for Myocardial Ischemia- A Preliminary Report.” Journal of Emergency Medicine 19: 311–315.
   PubMed Web of Science ®Google Scholar
• Bar-Or, D., J.V. Winkler, K. Vanbenthuysen, L. Harris, E. Lau, and F.W. Hetzel. 2001. “Reduced Albumin-Cobalt Binding with Transient Myocardial Ischemia After Elective Percutaneous Transluminal Coronary Angioplasty: A Preliminary Comparison to Creatine Kinase-Mb, Myoglobin, and Troponin I.” American Heart Journal 141: 985–991.
   PubMed Web of Science ®Google Scholar
• Bowie, E.A., and P.J. Hurley. 1975. “Cobalt Chloride in the Treatment of Refractory Anaemia in Patients Undergoing Long-Term Haemodialysis.” Australia and New Zealand Journal of Medicine 5: 306–314.
   PubMedGoogle Scholar
• Brodner, W., P. Bitzan, V. Meisinger, A. Kaider, F. Gottsauner-Wolf, and R. Kotz. 2003. “Serum Cobalt Levels After Metal-On-Metal Total Hip Arthroplasty.” Journal of Bone and Joint Surgery 85: 2168–2173.
   Google Scholar
• Catalani, S., R. Leone, M.C. Rizzetti, A. Padovani, and P. Apostoli. 2011. “The Role of Albumin in Human Toxicology of Cobalt: Contribution from a Clinical Case.” ISRN Hematology 2011: 690620.
   PubMedGoogle Scholar
• Davis, J.E., and J. P. Fields. 1958. “Experimental Production of Polycythemia in Humans by Administration of Cobalt Chloride.” Proceedings of the Society for Experimental Biology and Medicine 99: 493–495.
   PubMed Web of Science ®Google Scholar
• Duckham, J.M., and H.A. Lee. 1976. “The Treatment of Refractory Anaemia of Chronic Renal Failure with Cobalt Chloride.” Quarterly Journal of Medicine 45: 277–294.
   PubMedGoogle Scholar
• Engh, C.A. Jr, S.J. MacDonald, S. Sritulanondha, A. Thompson, D. Naudie, and C.A. Engh. 2009. “Metal Ion Levels After Metal-On-Metal Total Hip Arthroplasty: A Randomized Trial.” Clinical Orthopaedics and Related Research 467: 101–111.
   PubMed Web of Science ®Google Scholar
• Finley, B.L., A.D. Monnot, S.H. Gaffney, and D.J. Paustenbach. 2012. “Dose-Response Relationships for Blood Cobalt Concentrations and Health Effects: A Review of the Literature and Application of a Biokinetic Model.” Journal of Toxicology and Environmental Health B 15: 493–523.
   PubMed Web of Science ®Google Scholar
• Govender, R., J. De Greef, R. Delport, P.J. Becker, and W.J. Vermaak. 2008. “Biological Variation of Ischaemia-Modified Albumin in Healthy Subjects.” Cardiovascular Journal of Africa 19: 141–144.
   PubMed Web of Science ®Google Scholar
• Gross, R.T., J.P. Kriss, and T.H. Spaet. 1955. “The Hematopoietic and Goitrogenic Effects of Cobaltous Chloride in Patients With Sickle Cell Anemia.” Pediatrics 15: 284–290.
   PubMed Web of Science ®Google Scholar
• Jaimet, C.H., and H.G. Thode. 1955. “Thyroid function studies on children receiving cobalt therapy.” Journal of the American Medical Association 158: 1353–1355.
   PubMed Web of Science ®Google Scholar
• Jansen, H.M., S. Knollema, L.V. van der Duin, A.T. Willemsen, A. Wiersma, E.J. Franssen, F.G. Russel, J. Korf, and A.M. Paans. 1996. “Pharmacokinetics and dosimetry of cobalt-55 and cobalt 57.” Journal of Nuclear Medicine 37: 2082–2086.
   PubMed Web of Science ®Google Scholar
• Kerger, B.D., B.E. Tvermoes, K.M. Unice, B.L. Finley, D.J. Paustenbach, and D.A. Galbraith. 2013. “Cobalt Speciation Assay for Human Serum, Part II. Method Validation In a Study of Human Volunteers Ingesting Cobalt(II) Chloride Dietary Supplement for 90 Days.” Toxicological and Environmental Chemistry.
   Google Scholar
• Kesteloot, H., J. Roelandt, J. Willems, J.H. Claes, and J.V. Joossens. 1968. “An Enquiry into the Role of Cobalt in the Heart Disease of Chronic Beer Drinkers.” Circulation 37: 854–864.
   PubMed Web of Science ®Google Scholar
• Kriss, J.P., W.H. Carnes, and R.T. Gross. 1955. “Hypothyroidism and Thyroid Hyperplasia in Patients Treated with Cobalt.” Journal of the American Medical Association 157: 117–121.
   PubMed Web of Science ®Google Scholar
• Lippi, G., G. Brocco, G.L. Salvagno, M. Montagnana, F. Dima, and G.C. Guidi. 2005. “High-Workload Endurance Training May Increase Serum Ischemia-Modified Albumin Concentrations.” Clinical Chemistry and Laboratory Medicine 43: 741–744.
   PubMed Web of Science ®Google Scholar
• Mothes, E., and P. Faller. 2007. “Evidence that the Principal CoII-Binding Site in Human Serum Albumin is Not at the N-Terminus: Implication on the Albumin Cobalt Binding Test for Detecting Myocardial Ischemia.” Biochemistry 46: 2267–2274.
   PubMed Web of Science ®Google Scholar
• Nandedkar, A.K.N., P.K. Basu, and F. Friedberg. 1972. “Co++ Binding by Plasma Proteins.” Bioinorganic Chemistry 2: 149–157.
   Google Scholar
• Paustenbach, D., B. Tvermoes, K. Unice, B. Finley, and B. Kerger. 2013. “A Review of the Health Hazards Posed by Cobalt: Potential Importance of Free Divalent Cobalt Ion Equilibrium in Understanding Systemic Toxicity in Humans.” Critical Reviews in Toxicology 43: 316–362.
   PubMed Web of Science ®Google Scholar
• Polyzois, I., D. Nikolopoulos, I. Michos, E. Patsouris, and S. Theocharis. 2012. “Local and Systemic Toxicity of Nanoscale Debris Particles in Total Hip Arthroplasty.” Journal of Applied Toxicology 32: 255–269.
   PubMed Web of Science ®Google Scholar
• Sadler, P.J., A. Tucker, and J.H. Viles. 1994. “Involvement of a Lysine Residue in the N-Terminal Ni2+ and Cu2+ Binding Site of Serum Albumins. Comparison with Co2+, Cd2+ and Al3+.” European Journal of Biochemistry 220: 193–200.
   PubMedGoogle Scholar